Compare STE & CYBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STE | CYBR |
|---|---|---|
| Founded | 1985 | 1999 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9B | 24.0B |
| IPO Year | 1992 | 2014 |
| Metric | STE | CYBR |
|---|---|---|
| Price | $263.47 | $477.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 31 |
| Target Price | $268.25 | ★ $453.23 |
| AVG Volume (30 Days) | ★ 674.3K | 479.9K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | ★ 0.96% | N/A |
| EPS Growth | ★ 59.39 | N/A |
| EPS | ★ 6.97 | N/A |
| Revenue | ★ $5,702,415,000.00 | $1,302,851,000.00 |
| Revenue This Year | $9.24 | $36.30 |
| Revenue Next Year | $6.30 | $18.99 |
| P/E Ratio | $37.72 | ★ N/A |
| Revenue Growth | 7.08 | ★ 43.26 |
| 52 Week Low | $200.98 | $288.63 |
| 52 Week High | $268.60 | $526.19 |
| Indicator | STE | CYBR |
|---|---|---|
| Relative Strength Index (RSI) | 59.06 | 52.02 |
| Support Level | $256.68 | $451.84 |
| Resistance Level | $268.60 | $460.41 |
| Average True Range (ATR) | 4.64 | 11.89 |
| MACD | -0.69 | 1.91 |
| Stochastic Oscillator | 65.59 | 76.80 |
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
CyberArk is a cybersecurity vendor focused on the identity market. The company's core privileged access management offering is a market leader in that subsegment, with more than half of the Fortune 500 as CyberArk customers. The identity security vendor was founded in 1999 and has around 9,000 customers across various industries. While CyberArk historically sold its security solutions primarily via on-premises licenses, over the past few years it has transitioned to a subscription recurring-revenue model.